| Description: | HLA imputation values |
| Category: | Genomics ⏵ Genotypes ⏵ HLA |
| Genomics + Genotype results, process and QC |
| Participants | 487,713 | Value Type | Compound | Sexed | Both sexes | Debut | Mar 2016 | |||
| Item count | 487,713 | Item Type | Data | Instances | Singular | Version | Aug 2025 | |||
| Stability | Accruing | Strata | Derived | Array | No | Cost Tier | o1 s2 |
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Average compound dataset is 766b, largest is 962b.
A, B, C, DRB5, DRB4, DRB3, DRB1, DQB1, DQA1, DPB1, DPA1
There is one value (separated by commas) per imputed allele and only the best-guess alleles are reported. The quantities P(A1|D) and P(A2|D,A1) from the Q column of the HLA:IMP*2 output are reported for each locus. For further information on the calculation methodology and the Quality metric see Resource 182.
To download an example row of data see Resource 1520.
| Preview | Name | Res ID |
|---|---|---|
 | HLA data headers | 2182 |
 | Imputation of classical HLA types | 182 |
 | Imputed HLA values example | 1520 |
| Application ID | Title |
|---|---|
| 13721 | Causal associations of circulating biomarkers with cardiovascular disease |
| 19056 | Copy-number variants in Cardiovascular and Neuropsychiatric disorders |
| 21552 | Detection of large-scale copy-number and copy-neutral mosaic alterations in circulating leukocyte DNA of UK Biobank cancer cases and cancer-free controls |
| 5974 | Development and validation of risk prediction models for cancer. |
| 13352 | Evaluation of Association of TRPV4 Variation with Heart Failure, Respiratory, Renal and Menstruation Phenotypes |
| 7089 | Exome Sequencing of All Premature Coronary Artery Disease Participants in UK Biobank |
| 18219 | Genetic and epidemiological analyses of low back pain |
| 12885 | Genetic determinants of objective physical activity levels and fitness in the UK Biobank |
| 61650 | Genetic variation in sodium-glucose cotransporter 2 (SGLT2) and glucagon-like peptide-1 receptor (GLP1R) and cardiovascular outcomes |
| 23509 | Genome-wide and brain-wide association studies |
| 20915 | Genome-wide integrative and network-based approaches to obstructive lung diseases and their comorbidities |
| 31187 | Integrative Prioritization of Loci for Alcohol Use Disorders and Associated Complex Traits |
| 20175 | Nutrition, diet and health: examining causal associations and gene-environment interactions |
| 27837 | Statistical Methods for Large Scale Genetic Studies |
| 8447 | The genetic architecture and prediction of anthropomorphic measurements |
| 22783 | The joint analysis of imaging data and genetic data for early tumor detection, prevention, diagnosis and treatment |
Enabling scientific discoveries that improve human health